Table 1 Baseline clinical characteristics in IMN patients with and without DM

Age (years)

48 ± 15

60 ± 9

< 0.001

male (n, %)

94(57.3)

21 (50.0)

0.394

SBP (mmHg)

134 ± 20

137 ± 21

0.505

DBP (mmHg)

82 ± 12

78 ± 11

0.062

Hypertension (n, %)

71 (43.3)

17 (40.5)

0.742

Glomerular hematuria (n, %)

15 (9.1)

3 (7.1)

0.682

eGFR (ml/min/1.73m²)

91.5 ± 21.9

76.1 ± 27.1

0.001

Serum creatinine (μmol/L)

84 ± 45

96 ± 55

0.134

Proteinuria (g/24 h)

5.5 ± 3.8

7.2 ± 6.0

0.084

Albuminuria (g/24 h)

3.1 ± 2.1

3.4 ± 2.4

0.522

uPCR (mg/gCr)

4.4 ± 3.6

5.9 ± 4.9

0.074

uACR (mg/gCr)

2.4 ± 1.9

2.8 ± 2.2

0.173

Serum albumin (g/L)

22.4 ± 7.4

22.4 ± 5.7

0.943

Hemoglobin (g/L)

129.3 ± 20.2

120.3 ± 21.6

0.012

Blood uric acid (μmol/L)

427.2 ± 120.5

402.8 ± 103.8

0.232

Cholesterol (mmol/L)

8.7 ± 3.0

8.2 ± 2.5

0.349

Triglyceride (mmol/L)

3.1 ± 2.2

3.3 ± 2.1

0.588

HDL (mmol/L)

1.5 ± 0.5

1.5 ± 0.5

0.652

LDL (mmol/L)

5.5 ± 2.0

5.1 ± 1.7

0.233

Glycosylated hemoglobin (%)

5.6 ± 0.5

6.5 ± 1.0

< 0.001

Type 1 Diabetes

–

1 (2.4)

–

Type 2 Diabetes

–

31 (97.6)

–

Steroid diabetes

–

10 (23.8)

New-onset diabetes

–

27 (64.3)

–

Previous diabetes

–

15 (35.7)

–

Oral hypoglycemic drugs

–

27 (64.3)

–

Insulin

–

1 (2.4)

–

Lifestyle management

–

14 (33.3)

–